Socpra Sciences Et Genie S.e.c.

Her Majesty the Queen in Right of Canada, As Represented by the Minister of Agriculture and Agri-food

Tong, Alan Kwai-wah

Schaefer, Alan L.

Scott, Shannon L.

Lacasse, Pierre

Pierre Lacasse

François Malouin

Céline Ster

Marianne Allard

Brian Geoffrey Talbot

Daniel Scholl

Moussa Sory Diarra

Christian Lebeau Jacob

Alan Kwai-Wah Tong

André Bégin

Ali R Taherian

Barbara Bisakowski

Samuel Lanctôt

Patrick Fustier

Alan L Schaefer

Moussa S Diarra

Celine Ster

Shannon L Scott

Agents, compositions, methods and kits useful for the treatment and diagnosis of Staphylococcal intramammary infection are disclosed. The agents, compositions, methods and kits are derived from genes expressed during Staphylococcal intramammary infection, and more particularly genes SACOL0029, based on the gene nomenclature from theCOL (SACOL) genome.

Bacterial vaccine components and uses thereof

Agents, compositions, methods and kits useful for the treatment and diagnosis of Staphylococcal intramammary infection are disclosed. The agents, compositions, methods and kits are derived from genes expressed during Staphylococcal intramammary infection, and more particularly genes SACOL0442, based on the gene nomenclature from theaureus COL (SACOL) genome.

A method of preventing intramammary infection and accelerating involution by administration of a biological response modifier, specifically a chitosan solution, to the teat of a lactating mammal at drying-off A chitosan solution neutralized with a weak base such as &#x3b2;-glycerophosphate can remain liquid at room temperature for injection into a teat, but can form a hydrogel at body temperature inside the teat. The neutralized chitosan solution can also be optionally co-administered with a teat sealant.

Chitosan hydrogels for accelerating involution and preventing infection of the mammary gland at drying-off

Agents, compositions, methods and kits useful for the treatment and diagnosis of Staphylococcal intramammary infection are disclosed. The agents, compositions, methods and kits are derived from genes expressed during Staphylococcal intramammary infection, and more particularly genes SACOL0029, SACOL0264, SACOL0442, SACOL0718, SACOL0720, SACOL1353, SACOL1416, SACOL1611, SACOL1944, SACOL2144, SACOL2365 or SACOL2599, based on the gene nomenclature from theCOL (SACOL) genome.

[object Object]

Growing community of inventors

Sherbrooke, Canada

Pierre Lacasse